These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 14729088

  • 1. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
    Vila A, Sánchez A, Janes K, Behrens I, Kissel T, Vila Jato JL, Alonso MJ.
    Eur J Pharm Biopharm; 2004 Jan; 57(1):123-31. PubMed ID: 14729088
    [Abstract] [Full Text] [Related]

  • 2. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B, Somavarapu S, Li XW, Thanou M, Sesardic D, Alpar HO, Senel S.
    Int J Pharm; 2008 Nov 03; 363(1-2):139-48. PubMed ID: 18662762
    [Abstract] [Full Text] [Related]

  • 3. Immunoadjuvant potential of cross-linked dextran microspheres mixed with chitosan nanospheres encapsulated with tetanus toxoid.
    Pirouzmand H, Khameneh B, Tafaghodi M.
    Pharm Biol; 2017 Dec 03; 55(1):212-217. PubMed ID: 27927058
    [Abstract] [Full Text] [Related]

  • 4. PEG-PLA nanoparticles as carriers for nasal vaccine delivery.
    Vila A, Sánchez A, Evora C, Soriano I, Vila Jato JL, Alonso MJ.
    J Aerosol Med; 2004 Dec 03; 17(2):174-85. PubMed ID: 15294069
    [Abstract] [Full Text] [Related]

  • 5. Development and characterization of chitosan coated poly-(ɛ-caprolactone) nanoparticulate system for effective immunization against influenza.
    Gupta NK, Tomar P, Sharma V, Dixit VK.
    Vaccine; 2011 Nov 08; 29(48):9026-37. PubMed ID: 21939718
    [Abstract] [Full Text] [Related]

  • 6. Development and Optimization of Chitosan Nanoparticle-Based Intranasal Vaccine Carrier.
    Gao X, Liu N, Wang Z, Gao J, Zhang H, Li M, Du Y, Gao X, Zheng A.
    Molecules; 2021 Dec 29; 27(1):. PubMed ID: 35011436
    [Abstract] [Full Text] [Related]

  • 7. Foot and Mouth Disease virus-loaded fungal chitosan nanoparticles for intranasal administration: impact of formulation on physicochemical and immunological characteristics.
    Tajdini F, Amini MA, Mokarram AR, Taghizadeh M, Azimi SM.
    Pharm Dev Technol; 2014 May 29; 19(3):333-41. PubMed ID: 23590209
    [Abstract] [Full Text] [Related]

  • 8. ProJuvant (Pluronic F127/chitosan) enhances the immune response to intranasally administered tetanus toxoid.
    Westerink MA, Smithson SL, Srivastava N, Blonder J, Coeshott C, Rosenthal GJ.
    Vaccine; 2001 Dec 12; 20(5-6):711-23. PubMed ID: 11738734
    [Abstract] [Full Text] [Related]

  • 9. Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.
    Bento D, Staats HF, Gonçalves T, Borges O.
    Eur J Pharm Biopharm; 2015 Jun 12; 93():149-64. PubMed ID: 25818119
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chitosan-based nanoparticles for improving immunization against hepatitis B infection.
    Prego C, Paolicelli P, Díaz B, Vicente S, Sánchez A, González-Fernández A, Alonso MJ.
    Vaccine; 2010 Mar 19; 28(14):2607-14. PubMed ID: 20096389
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Novel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization.
    Yeh MK, Cheng KM, Hu CS, Huang YC, Young JJ.
    Acta Biomater; 2011 Oct 19; 7(10):3804-12. PubMed ID: 21742066
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Complexation as an approach to entrap cationic drugs into cationic nanoparticles administered intranasally for Alzheimer's disease management: preparation and detection in rat brain.
    Hanafy AS, Farid RM, ElGamal SS.
    Drug Dev Ind Pharm; 2015 Oct 19; 41(12):2055-68. PubMed ID: 26133084
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Application of Mucoadhesive Chitosan Nanoparticles in Nasal Drug Delivery.
    Shim S, Yoo HS.
    Mar Drugs; 2020 Nov 29; 18(12):. PubMed ID: 33260406
    [Abstract] [Full Text] [Related]

  • 19. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
    Lin A, Liu Y, Huang Y, Sun J, Wu Z, Zhang X, Ping Q.
    Int J Pharm; 2008 Jul 09; 359(1-2):247-53. PubMed ID: 18457928
    [Abstract] [Full Text] [Related]

  • 20. Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery.
    Xu B, Zhang W, Chen Y, Xu Y, Wang B, Zong L.
    Int J Biol Macromol; 2018 Jul 01; 113():534-542. PubMed ID: 29408613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.